Rhabdomyosarcoma, excluding all cancers (controls excluding all cancers)

C3_RHABDOMYOSARCOMA_EXALLC

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C48.4\|C49.4 Cause of death: ICD-10 — C48.4\|C49.4 Cancer registry: Topography ICD-O-3 — ANY Cancer registry: Morphology ICD-O-3 — 8900\|8901\|8910\|8920\|8963 Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	62
4. Check minimum number of events None	62
5. Include endpoints None	62
6. Filter based on genotype QC (FinnGen only)	62

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_RHABDOMYOSARCOMA_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C48.4\|C49.4
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C48.4\|C49.4
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	ANY
CANC_TOPO_EXCL
CANC_MORPH	8900\|8901\|8910\|8920\|8963
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Rhabdomyosarcoma, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Rhabdomyosarcoma

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	62	29	33
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	40.74	43.31	38.49

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4035726)

35.44

39.54

1.8

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

17.62

17.47

4.4

3.9

3.36

3.26

g/l

0.05

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

16.24

16.69

4.8

2.9

235.06

173.77

1.04

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

12.63

15.05

5.4

4.1

91.47

84.28

0.43

(3036489) Thrombin time

13.13

14.66

4.5

2.7

26.56

22.56

0.55

(3023368) Bacteria identified in Blood by Culture

113

7.10

13.62

7.9

3.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7.03

12.84

12.4

8.9

1.11

1.26

mmol/l

1.35

(40768804) Tissue Pathology biopsy report

146

6.34

11.64

3.2

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

100

5.92

11.17

5.2

2.0

—

(3044640) Blood type and Crossmatch panel - Blood

122

5.65

10.60

5.6

1.9

—

(40758558) Short blood count panel - Blood

128

5.32

9.86

30.1

5.2

—

(36304419) Bacteria [Presence] in Urine

116

5.28

9.77

6.2

3.0

—

(3030467) Casts [#/volume] in Urine by Automated count

122

4.96

9.05

6.3

3.0

0.15

0.36

e6/l

0.89

(3002256) Pathology report gross observation

7.09

9.03

1.3

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

135

4.66

8.35

6.2

2.9

123.58

566.02

e6/l

0.41

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5.55

8.29

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5.55

8.29

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

183

4.66

7.95

6.2

3.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

6.19

7.91

1.6

1.4

—

(3042936) Bacteria identified in Isolate by Culture

4.78

7.40

2.0

2.1

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

151

4.03

6.84

6.3

2.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4.39

6.66

1.8

1.6

—

(3018095) Leukocytes [#/volume] in Urine

163

3.88

6.47

8.4

3.5

35.34

75.54

e6/l

0.65

104

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

+∞

6.35

1.0

0.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4.00

5.88

6.4

3.1

2.75

1.71

e6/l

0.27

(3016244) Insulin [Units/volume] in Serum or Plasma

14.74

5.78

2.1

3.4

6.34

15.83

mu/l

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

217

3.63

5.55

18.3

8.2

1.21

1.22

mmol/l

0.49

196

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3.78

5.30

6.7

3.0

0.70

4.39

e6/l

—

(3032080) INR in Blood by Coagulation assay

149

3.37

5.25

9.7

6.8

1.30

1.36

inr

—

(42870588) Differential panel, method unspecified - Blood

174

3.32

5.12

24.9

4.6

—

(3000991) Gas panel - Venous blood

4.14

5.01

24.4

15.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3.89

5.00

1.8

1.7

—

(3026782) Osmolality of Urine

3.41

4.43

3.9

2.6

455.60

572.44

mosm/kgh2o

1.53

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4.27

4.15

5.7

13.8

111.08

123.27

g/l

0.97

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4.78

4.06

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

4.58

3.86

20.4

17.0

95.62

93.94

—

(3007853) Bacteria identified in Skin by Aerobe culture

3.28

3.77

1.5

2.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3.25

3.56

18.8

15.4

25.53

24.33

mmol/l

0.74

(3044290) Cell count panel - Cerebral spinal fluid

6.38

3.46

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

5.07

3.26

17.7

21.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

8.14

3.13

1.2

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2.80

3.03

1.9

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

7.23

2.94

1.2

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3.65

2.91

4.1

3.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

5.48

2.81

1.3

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

5.90

2.61

1.3

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

5.90

2.61

1.2

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

7.64

2.59

1.2

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

7.64

2.59

1.0

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

5.40

2.46

3.3

7.7

1.95

1.64

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

5.40

2.46

2.5

7.7

0.87

1.02

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

6.67

2.41

1.4

2.3

—

(3003694) ABO and Rh group [Type] in Blood

129

2.24

2.26

1.8

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

4.62

2.21

1.5

1.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

4.62

2.21

3.0

1.4

21.00

83.11

u/ml

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.42

2.14

2.0

2.6

180.40

272.01

ng/l

—

(3023410) Appearance of Cerebral spinal fluid

5.33

2.11

1.2

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

138

0.31

2.09

1.2

1.3

—

1.49

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

4.31

2.09

1.5

2.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2.76

2.06

29.9

6.2

24.27

24.08

mmol/l

0.13

(3012544) pH of Venous blood

2.43

1.87

29.5

8.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

106

2.14

1.85

1.6

2.2

—

(36660697) Celiac disease serology panel - Serum

0.00

1.79

0.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

4.08

1.75

1.2

2.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

3.78

1.65

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

3.78

1.65

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3.05

1.54

1.2

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.91

1.47

1.0

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

307

1.85

1.47

6.5

4.0

—

(3044889) 12 lead EKG panel

288

1.71

1.20

3.9

3.2

—

(3020891) Body temperature

2.63

1.17

2.8

4.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.63

1.17

1.0

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

426

1.90

1.15

64.0

13.1

14.14

13.51

2.29

418

(3015736) pH of Urine

170

1.67

1.08

4.2

3.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

493

2.02

1.03

40.2

10.6

34.04

22.43

mg/l

1.49

362

(3011397) Hemoglobin [Presence] in Urine by Test strip

112

1.71

0.98

5.5

3.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.18

0.92

25.7

10.8

112.83

130.21

g/l

—

(40761536) Microorganisms panel - Urine sediment

2.03

0.87

10.0

2.3

—

(3000494) Fungus identified in Specimen by Culture

1.86

0.85

1.3

1.4

—

(1761868) Lipid panel - Serum or Plasma

145

0.56

0.82

1.7

2.7

—

(3019060) Gas panel - Arterial blood

2.27

0.78

2.4

4.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2.27

0.78

5.6

8.0

64.06

51.36

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

411

1.59

0.78

33.9

8.9

90.20

85.84

ml/min/173m2

0.44

308

(3025941) Bacteria identified in Stool by Culture

2.17

0.76

1.2

1.3

—

(3026008) Bacteria identified in Urine by Culture

120

1.57

0.75

3.4

3.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

222

1.48

0.73

9.1

4.6

0.00

estimate

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2.00

0.72

2.8

6.7

24.24

24.67

mmol/l

—

(3017732) Neutrophils [#/volume] in Blood

1.85

0.67

3.2

1.9

2.26

3.73

e9/l

—

(3009261) Glucose [Presence] in Urine by Test strip

226

1.44

0.65

6.0

3.2

0.00

estimate

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.1

—

2.82

—

(3008898) HLA-B27 [Presence]

0.00

0.61

0.0

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

219

1.41

0.60

6.1

3.2

0.00

estimate

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.53

0.56

1.1

2.0

—

(3013512) EKG study

106

0.62

0.54

5.6

3.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

480

1.52

0.50

51.1

13.6

138.63

139.67

mmol/l

2.83

468

(3023103) Potassium [Moles/volume] in Serum or Plasma

480

1.52

0.50

51.2

13.7

3.90

3.98

mmol/l

1.45

466

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.56

0.42

1.8

1.2

—

(3022145) Colonoscopy Study observation

1.47

0.37

1.0

1.4

—

(3022313) Gas panel - Capillary blood

1.28

0.30

7.4

8.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.65

0.28

1.2

2.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

124

1.28

0.27

1.3

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.38

0.24

1.4

1.9

—

(40761511) CBC panel - Blood by Automated count

497

1.29

0.23

23.6

9.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.21

0.0

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.5

—

2.56

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

3.81

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.21

0.0

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

9.63

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

119

1.23

0.20

2.9

2.2

71.64

58.64

u/l

0.49

108

(3029937) Albumin [Presence] in Urine by Test strip

110

1.23

0.19

5.4

3.2

0.00

estimate

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.19

0.18

1.1

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1.16

0.17

2.0

1.8

1.61

1.34

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

162

1.16

0.14

2.1

1.8

93.19

99.43

pmol/l

0.18

(3022217) INR in Platelet poor plasma by Coagulation assay

1.15

0.10

29.8

23.9

—

1.13

—

(3010813) Leukocytes [#/volume] in Blood

556

0.90

0.08

63.6

15.6

6.20

6.84

e9/l

1.31

532

(3035941) MCH [Entitic mass]

555

0.92

0.08

63.4

15.5

29.98

29.95

0.04

547

(3000963) Hemoglobin [Mass/volume] in Blood

555

0.92

0.08

66.3

15.7

122.42

137.35

g/l

6.94

547

(3026361) Erythrocytes [#/volume] in Blood

555

0.92

0.08

63.5

15.6

4.11

4.61

e12/l

7.31

531

(3007461) Platelets [#/volume] in Blood

554

0.94

0.08

63.7

15.6

243.80

253.66

e9/l

0.39

532

(3024731) MCV [Entitic volume]

554

0.94

0.08

63.6

15.6

90.28

89.42

0.60

546

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.85

0.07

2.3

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.87

0.07

1.1

2.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

121

0.89

0.06

6.6

2.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

359

1.08

0.05

2.9

3.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

117

0.93

0.02

1.2

1.6

1.08

1.47

mmol/l

1.67

104

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

163

0.98

0.00

5.0

3.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

0.0

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

0.0

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.02

0.00

4.6

7.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.0

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

0.00

0.0

4.7

—

0.78

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.00

0.0

1.8

—

0.35

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.0

2.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.42

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

0.0

2.5

—

12.95

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

1.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

0.96

0.00

9.1

4.5

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

1.9

—

4.04

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

2.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

1.2

—

691.40

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

1.9

—

107.71

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.0

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(4094501)

0.00

0.0

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

0.0

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_RHABDOMYOSARCOMA_EXALLC – Rhabdomyosarcoma, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Rhabdomyosarcoma, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Rhabdomyosarcoma, excluding all cancers (controls excluding all cancers) (C3_RHABDOMYOSARCOMA_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Relationships between endpoints